info@cancercarespecialtiesmena.com
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases
- Home
- Publications
- The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases
Latest News
Understanding Irritable Bowel Syndrome (IBS)
21 May, 2025Free second opinion in all our cancer centers
07 May, 2025Fuel Up Your Body with a Healthy Diet
27 Apr, 2025
Seminar & Events
Baghdad clinic
30 Sep, 2024Saudi German Hospital
26 Sep, 2024Oncology Program
16 Sep, 2024Oncology marketing
06 Sep, 2024CAR-T THERAPY
14 Aug, 2024
